COVID-19
Document de presse
2022.10.21
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by...
News
2022.09.05
We are looking for volunteers to take part in the CORSER-5 study. The study was launched in March 2022 to compare the immunity of COVID-19-positive individuals...
Document de presse
2022.07.21
COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties...
Document de presse
2022.07.13
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses...
News
2022.07.01
As a first-line laboratory in the event of a health emergency, the Pasteur Center in Cameroon was naturally designated as a COVID-19 reference laboratory by...
News
2022.06.08
A lesser known but equally crucial dimension in managing and responding to an epidemic is social sciences in health, which can shed light on populations'...
Document de presse
2022.05.03
For the past two years, the COVID-19 pandemic has exerted pressure on the hospital system, with consequences for patients' care pathways. To support hospital...
Portrait
2022.03.29
It all started with a veterinarian and a cross-eyed lion
Jean-Claude Manuguerra was 7 when he decided that he wanted to become a veterinarian, to "save animals...
News
2022.01.12
French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on...
Document de presse
2021.12.23
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the...